COMMUNIQUÉS West-GlobeNewswire

CURE Pharmaceutical Adds Healthcare Luminary To Advisory Board, Secures $1 Million Investment as a Bridge to Uplisting
21/02/2018
OXNARD, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced Gene Salkind, M.D. joined the company’s Advisory Board and also [...]
New medicine for house dust mite allergic rhinitis and allergic asthma now available in France
21/02/2018
Copenhagen, 2018-02-21 10:00 CET (GLOBE NEWSWIRE) -- Allergy immunotherapy company ALK today announced that its sublingual allergy immunotherapy (SLIT) tablet ACARIZAX ® is now available on prescription in France for [...]
Zealand Pharma reports completion of the first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia
21/02/2018
Press release - No. 5/2018 Zealand Pharma reports completion of the first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia Last patient visit concluded in the multinational Phase 3 trial, with [...]
Veritas Pharma Provides Corporate Update on Q1 2018
21/02/2018
VANCOUVER, British Columbia, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to provide an official corporate update on its [...]
Saniona AB: Saniona publishes its year-end report for 2017
21/02/2018
PRESS RELEASE February 21, 2018 Financial highlights Jan - Dec 2017 (Jan - Dec 2016) · Net revenues were SEK 20.7 M (74.9 M) · EBIT was SEK -57.2 M (4.2 M) · Net profit/loss was SEK -49.2 M (2.2 M) · Earnings per share [...]
Motif Bio to Present Iclaprim Data at ECCMID 2018
21/02/2018
Phase 3 trial results for REVIVE-2 in patients with ABSSSI Potential cost savings opportunities with iclaprim versus vancomycin Iclaprim in vitro susceptibility data NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Motif Bio [...]
NeuroSearch – Updated financial calendar for 2018
21/02/2018
Announcement no. 2-18 Page 1 of 1 Announcement 21 February 2018 NeuroSearch A/S (NEUR) hereby announces an update on the company’s financial calendar for 2018. 30 April 2018 Annual General Meeting 30 August 2018 Interim [...]
Basilea's CEO Ronald Scott will retire. Chief Commercial Officer David Veitch named as successor. Changes in the Board of Directors
21/02/2018
Basel, Switzerland, February 21, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that Chief Executive Officer Ronald Scott will retire after 18 years with the company. Basilea's Board of Directors has [...]
ProPhase Labs, Inc. Announces New Compensatory Arrangement With Chief Executive Officer and Termination of Stockholder Rights Plan
21/02/2018
DOYLESTOWN, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ) ( www.ProPhaseLabs.com ), a vertically integrated and diversified branding, marketing and technology company with deep experience in [...]
National Research Corporation Declares Quarterly Dividend
21/02/2018
Lincoln, Nebraska, Feb. 20, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRCIA and NRCIB) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 (ten cents) per [...]
Portola Pharmaceuticals Announces Results of CHMP Oral Explanations for Andexanet Alfa and Betrixaban
20/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines [...]
Amarin to Report Fourth Quarter and Full Year 2017 Results and Host Conference Call on February 27th, 2018
20/02/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
AIT Therapeutics Appoints Two Senior Executives in Research and Clinical Operations
20/02/2018
Mark Rimkus Appointed VP of Clinical Affairs and Dr. Abdi Ghaffari Appointed VP of Research Appointments Add Decades of Nitric Oxide Experience to Team NEW YORK, Feb. 20, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. ( [...]
Spring Bank Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial and Operational Results
20/02/2018
2017 highlighted by continued progress with global inarigivir clinical program for the treatment of chronic HBV and advancement of next-generation STING agonist candidate, SB 11285, towards the clinic Multiple potential [...]
Inovalon Reports Fourth Quarter and Full Year 2017 Results
20/02/2018
Fourth Quarter 2017 Highlights Fourth quarter revenue of $114.6 million, up 19% year-over-year Fourth quarter net income of $17.4 million, resulting in diluted net income of $0.12 per share, inclusive of a one-time [...]
Dova Pharmaceuticals, Inc. Announces Proposed Offering of Common Stock
20/02/2018
DURHAM, N.C., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases where there is [...]
Quotient Limited Announces the Sale and Leaseback of its Edinburgh, Scotland Manufacturing and R&D Facility
20/02/2018
JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced it has entered into definitive agreements for the sale and leaseback [...]
Ultragenyx Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Update
20/02/2018
NOVATO, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported [...]
Avid Bioservices Announces Closing of Public Offering of Common Stock
20/02/2018
TUSTIN, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ) today announced the closing of its previously announced underwritten public offering of 10,294,445 shares of its [...]

Pages